4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile, 95.0%, 200mg

(R)-3-((tert-Butoxycarbonyl)amino)-4-(4-nitrophenyl)butanoic acid, 95.0%, 250mg

5-Bromo-2,4,6-trichloropyrimidine, 95.0%, 250mg

3-(4-Ethynylphenyl)propanoic acid, 98%, 100mg

Ethyl 4-(3,5-dimethyl-4-methoxyphenyl)-4-oxobutyrate, 97.0%, 1g

1-(5-Bromopyridin-3-yl)cyclopropane-1-carbonitrile, 97%, 250mg

4-(METHOXYMETHYL)PIPERIDIN-4-OL HYDROCHLORIDE, 95%, 100mg

(2S,4R)-1-((S)-14-amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamidehydrochloride, 95%, 2g

Z-5-decen-1-ol, 92%, 250mg

Ethyl 3-hydroxy-2-methylbenzoate, 97%, 1g

Decyl acrylate, 97% +(stabilized with MEHQ), 250mg

alpha-Methyl-2-trifluoromethylbenzyl alcohol, 97.0%, 25g

Norbornane-2-methanol (endo- and exo- mixture)>95.0%(GC)25mL